Open AccessMedullary Thyroid Cancer Patient’s Assessment of Quality of Life Tools: Results from the QaLM Study
Author(s) -
Laura Moss,
Catrin Cox,
Jonathan Wadsley,
Kate Newbold,
Mark W. J. Strachan,
Maralyn Druce,
Neil Tolley,
Kathryn Graham,
Sarah Jefferies,
L. Fresco,
S. Sivabalasingham,
Alistair Balfour,
Chris Hurt
Publication year - 2020
Publication title -
european thyroid journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.23
H-Index - 10
eISSN - 2235-0802
pISSN - 2235-0640
DOI - 10.1159/000509227
Subject(s) - medicine , medullary thyroid cancer , thyroid cancer , quality of life (healthcare) , disease , thyroid , cancer , stage (stratigraphy) , oncology , pediatrics , nursing , paleontology , biology
Medullary thyroid cancer (MTC) is a neuroendocrine tumour and a rare variant of thyroid cancer with different aetiology, presentation and treatment to differentiated thyroid cancer. Currently available thyroid cancer-specific quality of life (QoL) tools focus on issues and treatments more relevant to patients with differentiated thyroid cancer and therefore may not address issues specific to a MTC diagnosis and cancer journey.